AMZN
Amazon.com, Inc.
AMZN has the edge over MCFT overall, supported by stronger modeled upside and stronger valuation.
MCFT
MasterCraft Boat Holdings, Inc.
MCFT trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MCFT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Healthy | |
| Strong |
MCFT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MCFT in the historical PE scenario, which offers more potential upside but is not a forecast.
MCFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $1.21 | -94% |
| Fair | 9.3x | $1.67 | -92% |
| Expensive | 24x | $4.36 | -80% |
| Current | 120x | $21.59 | — |
Historical ranges are pointers, not guarantees.
MCFT's PE is in its expensive range at 120x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MCFT Forward outlook
There aren't enough analyst estimates for MCFT to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MCFT on earnings, with more consistent year-over-year improvement.
MCFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.18 | -81% |
| Q2 2026 | -$0.10 | -123% |
| Q1 2026 | $0.68 | +$1.05 |
| Q4 2025 | $0.96 | +$1.34 |
| Q3 2025 | $0.97 | +$1.18 |
| Q2 2025 | $0.44 | -4.3% |
| Q1 2025 | -$0.37 | -117% |
| Q4 2024 | -$0.38 | -112% |
MCFT's earnings per share have fallen from their peak: $0.18 over the past year, against $4.04 in late 2023.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MCFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MCFT on profitability, with a higher operating margin.
MCFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $154.1M | +123% |
| Q2 2026 | $129.9M | +63% |
| Q1 2026 | $78.2M | +3% |
| Q4 2025 | $71.8M | +13% |
| Q3 2025 | $69M | +5.6% |
| Q2 2025 | $79.5M | +18% |
| Q1 2025 | $76M | -21% |
| Q4 2024 | $63.4M | -36% |
MCFT's revenue is recovering but still below its 2022 peak: $154M last quarter, up 123% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | +2.3 points |
| Q2 2026 | -4.9% | -12 points |
| Q1 2026 | -1.7% | -7.1 points |
| Q4 2025 | 3.8% | +3.5 points |
| Q3 2025 | 5.5% | +3.9 points |
| Q2 2025 | 7.5% | +25 points |
| Q1 2025 | 5.4% | +1.2 points |
| Q4 2024 | 0.3% | -6.8 points |
MCFT's operating margin was 7.8% last quarter, up 2.3 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MCFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +$12.8M |
| Q2 2026 | $14.6M | -18% |
| Q1 2026 | $3.8M | -13% |
| Q4 2025 | $14M | +245% |
| Q3 2025 | -$9.9M | -5083% |
| Q2 2025 | $17.9M | +$31.4M |
| Q1 2025 | $4.3M | +$5.2M |
| Q4 2024 | $4M | -83% |
MCFT has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over MCFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MCFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +51% | +8.2M shares |
| 1 year | +48% | +7.9M shares |
| 3 years | +39% | +6.8M shares |
| 5 years | +28% | +5.3M shares |
| Available history | +30% | +5.5M shares |
MCFT has 24M diluted shares, up 48% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.8M |
| Q2 2026 | $12,000 |
| Q1 2026 | — |
| Q4 2025 | $15,000 |
| Q3 2025 | $2.3M |
| Q2 2025 | $4.5M |
| Q1 2025 | $749,000 |
| Q4 2024 | $749,000 |
MCFT spent $5M buying back its own shares over the past year, down 42% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MCFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -3.5x | Net Cash |
| Q1 2026 | -3.7x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -8.8x | Net Cash |
| Q4 2024 | -10.1x | Net Cash |
MCFT has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MCFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 32.4 | Neutral |
MCFT's weekly RSI is 49 (neutral) and its Stochastic is 32 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over MCFT on valuation relative to its sector.
MCFT PE vs Consumer Cyclical Sector
| Metric | MCFT | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 18x | 565% above |
| PE % | 100 | 47 | 53 pts above |
MCFT is trading at 120x earnings, a 565% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MCFT on trend strength, trading above more of its moving averages.
MCFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 6.1% above |
| 20 week MA | $22.3 | 3.2% below |
| 50 week MA | $22.1 | 2.4% below |
| 100 week MA | $20.5 | 5.2% above |
| 200 week MA | $22.0 | 1.8% below |
MCFT's trend is mixed: it's above two of its five weekly moving averages, and 1.8% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over MCFT on returns for 2026, with the stronger performance.
MCFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $26.7 | +73% |
| 2021 | $26.7 | $26.3 | -1.6% |
| 2022 | $26.3 | $26.2 | -0.3% |
| 2023 | $26.2 | $22.6 | -14% |
| 2024 | $22.6 | $18.7 | -17% |
| 2025 | $18.7 | $19.5 | +4.1% |
| 2026 YTD | $19.5 | $21.6 | +11% |
MCFT has finished lower in four of the last six years. It's up 11% so far in 2026.